N.V. POPOVA, A.P. GOYDIN

The Tambov Branch of the S. Fyodorov Eye Microsurgery Federal State Institution, 1 Rasskazovskoe shosse, Tambov, Russian Federation, 392000

Popova N.V. ― ophthalmologist of the Department of Laser Surgery, tel. (4752) 72-24-78, e-mail: naukatmb@mail.ru

Goydin A.P. ― Head of the Department of Laser Surgery, tel. (4752) 72-24-78, e-mail: naukatmb@mail.ru

The paper presents the results of studying the micro-pulse laser influence efficacy in treating patients with central serous chorioretinopathy. 41 patients diagnosed with central serous chorioretinopathy were included in the study. The follow-up period varied from 1 to 6 months. All patients were divided into two groups. The study group comprised 19 patients who underwent micro-pulse laser influence with a wavelength 810 nm. The control group comprised 22 patients (22 eyes) in whom the natural process was observed. In a month after treatment, all patients of the study group noted visual acuity increase from 0.5±0.083 to 0.8±0.031. According to OCT data, neuroepithelium detachment became planer, the height decreased from 446 to 341.3 µ at average. In 5 patients with chronic course of the process there was revealed a recurrence of the disease accompanied by the emergence of the filtration point in the other retinal zone, the development of the serous neuroepithelium detachment, deterioration in visual acuity, which required the additional session of micro-pulse laser influence. Mean interval between sessions was 4 months. After 3 months of follow-up, all patients had the complete adhering of neurosensor retina, visual acuity increased up to 0.9-1.0. The obtained data suggest that the use of micro-pulse regimen of the infrared laser allows performing laser interventions without functional PE and NE damage with the minimal risk for recurrence and choroidal neovascularization. The recurrence of the disease in 5 cases demonstrates the need for the improvement of the energy parameters of such influence.

Key words: central serous chorioretinopathy, pigment epithelium, micro-pulse laser influence, fluorescent angiography, neuroepithelium.

REFERENCES

1. Shchegoleva I.V., Budzinskaya M.V. The etiology and pathogenesis of central serous chorioretinopathy. Vestnik oftal’mologii, 2010, no. 3, pp. 55-58 (in Russ.).
2. Yannuzzi L.A. Type A behavior and central serous chorioretinopaty. Trans. Am. Ophthalmol. Soc, 1986, vol. 84, pp. 799-845.
3. Carvalho- Recchia C.A., Yannuzzi L.A., Negrao S., et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology, 2002, vol. 109, pp. 1834-1837 (in Russ.).
4. Gatsu M. V., Iskenderova N. G. Vliyanie steroidnoy terapii na razvitie i techenie tsentral’noy seroznoy khorioretinopatii [Effect of steroid therapy on the development and course of central serous chorioretinopathy]. Tez. dokl. III Vserossiyskogo seminara “kruglyy stol” – “Makula 2010”. Rostov on Don, 2010. Pp. 427-429.
5. Goydin A.P., Pronichkina M.M., Yablokova N.V., Krylova I.A. Current concepts of etiology, pathogenesis, clinical manifestations and treatment of central serous chorioretinopathy. Vestnik Tambovskogo universiteta. Seriya Estestvennye i tekhnicheskie nauki, 2015, vol. 20, iss. 4, pp. 784-791 (in Russ.).
6. Balashevich L.I., Kasimov E.M., Iskanderova N.G. et al. Current concepts of etiology and pathogenesis of central serous horiopatii. Oftal’mokhirurgiya, 2007, no. 2, pp. 63-67 (in Russ.).
7. Kitaya N., Nagaoka T., Hikichi T., et al. Features of abnormal choroidal circulation in central serous chorioretinopathy. Br. I. Ophthalmol, 2003, vol. 87, pp. 709-712.
8. Imamura Y., Fujiwara T., Margolis R. et al Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina, 2009, vol. 29, pp. 1469-1473.
9. Sekiryu T., Iida T., Maruko I. et al Infared Fundus Autofluorescence and Central Serous Chorioretinopathy. Investigative Ophthalmology & Visual Science, 2010, vol. 51, no. 10, rr. 4956-4962.
10. Iida T., Kishi S., Hagimura N. et al Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina, 1999, vol. 19, pp. 508-512.
11. Katsnel’son L.A., Forofonova T.I., Bunin A.Ya. Sosudistye zabolevaniya glaz [Vascular diseases of the eye]. Moscow: Meditsina, 1990. P. 270.
12. Kamppeter B., Jonas J. B. Central serous chorioretinopathy imaged by optical coherence tomography. Arch. Ophthalmol, 2003, vol. 121, pp. 742-743.
13. Wang M., Sander B. Retinal atrophy in central serous chorioretinopathy. Am. J. Ophtalmol, 2002, vol. 133, pp. 787-793.
14. Ross A., Ross A.H. Quersh Mohamed Review and update of central serous chorioretinopathy. Curr. Opin. Ophthalmol, 2011, vol. 22, pp. 166-173.
15. Marmor M.F. New hypotheses on the pathogenesis and treatment of serous retinal detachment. Graefes Arch. Clin. Exp. Ophthalmol, 1988, vol. 226, pp. 548-552.
16. Creenstein V.C., Chen H., Hood D.C. et al. Retinal functions in diabetic macular edema after focal laser photocoagulation. Invest. Ophthalmol Vis. Sci, 2000, vol. 41, no. 11, rr. 3655-3664.
17. Ruflege B.K., Wallow I.H., Poulsen G.L. Sub-pigment epithelial membranes after photocoagulation diabetic macular edema. Arch. Ophthalmol, 1993, vol. 111, pp. 608-613.
18. Eliseeva E.G., Pereverzina O.K. et al. Argonovyy lazer v lechenii tsentral’nykh seroznykh khorioretinopatiy [Argon laser in the treatment of central serous chorioretinopathy]. Lazernye metody lecheniya v oftal’mologii. Moscow, 1984. Pp. 114-121.
19. Gupta B., Elagouz M., Mc Hugh D. et al. Micropulse diode laser photocoagulation for central serous chorioretinopathy. Clin. Experiment. Ophthalmol, 2009, Nov, 37 (8), pp. 801-5.
20. Lanzetta P., Furlan F., Morgante L., Veritti D. Nonvisible subthreshold micropulse diod laser (810 nm) treatment of central serous chorioretinopathy. A pilot study. Eur. I. Ophthalmol, 2008, Nov.-Dec, 18 (6), pp. 934-40.
21. Koss M.I., Beger I., Koch F.H. Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy. Eye (Lond), 2012, Feb, 26 (2), pp. 307-14.